- Home
- BMO vs SYK Comparison
BMO vs SYK Comparison
Compare BMO & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMO | SYK |
|---|---|---|
| Founded | 1817 | 1941 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.2B | 120.7B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMO | SYK |
|---|---|---|
| Price | $176.38 | $341.12 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 14 |
| Target Price | $163.00 | ★ $415.57 |
| AVG Volume (30 Days) | 551.4K | ★ 2.2M |
| Earning Date | 05-27-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.25% | 1.12% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 5.23 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | $19.43 | $9.80 |
| Revenue Next Year | $4.27 | $8.44 |
| P/E Ratio | ★ $17.46 | $63.36 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $112.21 | $281.00 |
| 52 Week High | $187.22 | $396.86 |
Technical Indicators
Market Signals| Indicator | BMO | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 54.12 |
| Support Level | $173.99 | $321.72 |
| Resistance Level | $184.21 | $351.68 |
| Average True Range (ATR) | 2.91 | 9.26 |
| MACD | -0.43 | -1.29 |
| Stochastic Oscillator | 6.17 | 71.03 |
Price Performance
Historical ComparisonAbout BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. About 60% of BMO's earnings are generated in Canada and 40% in the US.
About SYK Stryker Corporation
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.